wang2019 {metawho} | R Documentation |
Hazard ratio (HR) for disease progression analysis comparing TMB-high with TMB-low in three NSCLC datasets
Description
Hazard ratio (HR) for disease progression analysis comparing TMB-high with TMB-low in three NSCLC datasets
Format
a data.frame
Source
Wang, Shixiang, et al. "The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients' sex." International journal of cancer (2019).
Examples
data("wang2019")
[Package metawho version 0.2.0 Index]